Skip to main content
Journal cover image

Phase II trial of imatinib mesylate plus hydroxyurea in the treatment of patients with malignant glioma

Publication ,  Conference
Reardon, D; Friedman, A; Herndon, J; Quinn, J; Rich, J; Vredenburgh, J; Badruddoja, M; Desjardins, A; Sampson, J; Gururangan, S; Dowell, J ...
Published in: NEURO-ONCOLOGY
October 1, 2004

Duke Scholars

Published In

NEURO-ONCOLOGY

ISSN

1522-8517

Publication Date

October 1, 2004

Volume

6

Issue

4

Start / End Page

381 / 381

Location

Toronto, CANADA

Publisher

DUKE UNIV PRESS

Conference Name

9th Annual Meeting of the Society-for-Neuro-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Reardon, D., Friedman, A., Herndon, J., Quinn, J., Rich, J., Vredenburgh, J., … Friedman, H. (2004). Phase II trial of imatinib mesylate plus hydroxyurea in the treatment of patients with malignant glioma. In NEURO-ONCOLOGY (Vol. 6, pp. 381–381). Toronto, CANADA: DUKE UNIV PRESS.
Reardon, D., A. Friedman, J. Herndon, J. Quinn, J. Rich, J. Vredenburgh, M. Badruddoja, et al. “Phase II trial of imatinib mesylate plus hydroxyurea in the treatment of patients with malignant glioma.” In NEURO-ONCOLOGY, 6:381–381. DUKE UNIV PRESS, 2004.
Reardon D, Friedman A, Herndon J, Quinn J, Rich J, Vredenburgh J, et al. Phase II trial of imatinib mesylate plus hydroxyurea in the treatment of patients with malignant glioma. In: NEURO-ONCOLOGY. DUKE UNIV PRESS; 2004. p. 381–381.
Reardon, D., et al. “Phase II trial of imatinib mesylate plus hydroxyurea in the treatment of patients with malignant glioma.” NEURO-ONCOLOGY, vol. 6, no. 4, DUKE UNIV PRESS, 2004, pp. 381–381.
Reardon D, Friedman A, Herndon J, Quinn J, Rich J, Vredenburgh J, Badruddoja M, Desjardins A, Sampson J, Gururangan S, Dowell J, Affronti M, Allen D, Jackson S, Zeigler K, Silverman S, Tourt-Uhlig S, Salvado A, Nikolova Z, Bigner D, Friedman H. Phase II trial of imatinib mesylate plus hydroxyurea in the treatment of patients with malignant glioma. NEURO-ONCOLOGY. DUKE UNIV PRESS; 2004. p. 381–381.
Journal cover image

Published In

NEURO-ONCOLOGY

ISSN

1522-8517

Publication Date

October 1, 2004

Volume

6

Issue

4

Start / End Page

381 / 381

Location

Toronto, CANADA

Publisher

DUKE UNIV PRESS

Conference Name

9th Annual Meeting of the Society-for-Neuro-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences